Geode Capital Management’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $22.5K | Hold |
|
|||||
|
2022
Q4 | $27K | Sell |
|
|||||
|
2022
Q3 | $108K | Hold |
|
|||||
|
2022
Q2 | $177K | Buy |
|
|||||
|
2022
Q1 | $269K | Hold |
|
|||||
|
2021
Q4 | $254K | Hold |
|
|||||
|
2021
Q3 | $439K | Buy |
|
|||||
|
2021
Q2 | $660K | Buy |
|
|||||
|
2021
Q1 | $270K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $22K | Hold |
|
|||||
|
2019
Q2 | $36K | Hold |
|
|||||
|
2019
Q1 | $53K | Hold |
|
|||||
|
2018
Q4 | $53K | Buy |
|
|||||
|
2018
Q3 | $111K | Hold |
|
|||||
|
2018
Q2 | $95K | Buy |
|
|||||
|
2018
Q1 | $144K | Hold |
|
|||||
|
2017
Q4 | $161K | Hold |
|
|||||
|
2017
Q3 | $235K | Hold |
|
|||||
|
2017
Q2 | $344K | Buy |
|
|||||
|
2017
Q1 | $334K | Buy |
|
|||||
|
2016
Q4 | $55K | Hold |
|
|||||
|
2016
Q3 | $72K | Hold |
|
|||||
|
2016
Q2 | $82K | Hold |
|
|||||
|
2016
Q1 | $117 | Hold |
|
|||||
|
2015
Q4 | $136K | Sell |
|
|||||
|
2015
Q3 | $330K | Buy |
|
|||||
|
2015
Q2 | $496K | Buy |
|
|||||
|
2015
Q1 | $312K | Hold |
|
|||||
|
2014
Q4 | $266K | Buy |
|
|||||
|
2014
Q3 | $358K | Hold |
|
|||||
|
2014
Q2 | $448K | Hold |
|
|||||
|
2014
Q1 | $599K | Buy |
|
|||||
|
2013
Q4 | $384K | Buy |
|
|||||
|
2013
Q3 | $229K | Buy |
|